Navigation Links
Driver of anthrax toxicity could lead to late-stage therapy

nd the "protective antigen carrier" of anthrax toxin, allowing its delivery into cells.

The new findings "reveal a previously unsuspected biological role" for LRP6, a gene earlier found to play important roles in pathways underlying early development and cell proliferation, the researchers said. The discovery also suggests potential new avenues for treating late-stage anthrax disease, they added.

While antibiotics, such as Cipro, can fight the anthrax bacteria when the disease is caught early, such drugs do nothing to dispel the accumulated toxin, the researchers explained. In contrast, drugs that target the host protein LRP6, or other components of the host machinery integral to the toxin's internalization, might offer a novel method to prevent the toxin from infiltrating and killing cells.

"Our discovery of the role of LRP6 in anthrax toxicity and the demonstration that antibodies directed against the extracellular domain of LRP6 can protect cells grown in culture against killing by anthrax toxin suggest that the immunological targeting of LRP6 may prove useful in protecting against the effects of accumulated toxin during the late stages of anthrax disease when antibacterial methods normally are no longer of therapeutic value," the researchers wrote.


'"/>

Source:Cell Press


Page: 1 2

Related biology news :

1. Scientists seek answers on what activates deadly anthrax spores
2. Antibodies from plants protect against anthrax
3. Defensins neutralize anthrax toxin
4. Critical step traced in anthrax infection
5. US Army plans to bulk-buy anthrax
6. New antibody shows promise as cure for anthrax
7. Effective, safe anthrax vaccine can be grown in tobacco plants
8. UCSD study finds anthrax toxins also harmful to fruit flies
9. Scientists design potent anthrax toxin inhibitor
10. Newly discovered protein kills anthrax bacteria by exploding their cell walls
11. Combating anthrax: Results of study published this month as researchers look for a better vaccine
Post Your Comments:
(Date:2/8/2010)... Feb. 8 With the recent election ... resulting in the loss of the Democratic supermajority, ... promise of universal coverage for the majority of uninsured ... Equity Research.  President Obama recently noted the country is ... has been for many a long sought after social ...
(Date:2/7/2010)... the National Cancer Institute (NCI) have found that the ... cancer among women without a personal history of breast ... the risk of developing breast cancer in women who ... of this survey are published in the February issue ... journal of the American Association for Cancer Research. ...
(Date:2/7/2010)... tricholorethylene (TCE), a chemical once widely used to clean ... significantly higher risk of developing Parkinson,s disease, according to ... the American Academy of Neurology,s 62nd Annual Meeting in ... is the first time a population-based study has confirmed ... person,s risk of developing Parkinson,s disease," said study author ...
Breaking Biology News(10 mins):S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 2S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 3S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 4S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 5S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 6S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 7S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 8S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now? 9Few women take tamoxifen to prevent breast cancer 2Ginkgo herbal medicines may increase seizures in people with epilepsy 65276 1One Type A Trait May Actually Lower Work Stress 65271 1FreightWatch Security Net Launches Solution for Tracking and Rescuing Persons at Risk of Wandering 65267 1FreightWatch Security Net Launches Solution for Tracking and Rescuing Persons at Risk of Wandering 65267 2FreightWatch Security Net Launches Solution for Tracking and Rescuing Persons at Risk of Wandering 65267 3FreightWatch Security Net Launches Solution for Tracking and Rescuing Persons at Risk of Wandering 65267 4
... team of Texas Agricultural Experiment Station scientists will ... to protect crops, which has implications for both ... Trichoderma virens, is used to protect field crops ... sequencing work may uncover chemical compounds and beneficial ...
... the first active vaccine that can significantly delay and possibly ... is similar to mad cow disease. The new findings, published ... platform for the development of a vaccine to prevent a ... called prions. , Although no cure for these diseases -- ...
... sub-Saharan Africa are threatened daily by a deadly parasitic ... caused by organisms called trypanosomes, which are spread by ... people in sub-Saharan Africa, a quarter of whom will ... genetic strategy for evading the human immune system and ...
Other Biology News:Experiment station researchers to explore genome of disease-fighting fungus 2Active Vaccine Prevents Mice From Developing Prion Disease 2Active Vaccine Prevents Mice From Developing Prion Disease 3Newly discovered protein an important tool for sleeping sickness research 2
(Date:2/9/2010)... SAN FRANCISCO , Feb. 9 /PRNewswire/ ... in Integrated Voice Response (IVR)/Integrated Web Response (IWR) ... platform that allows users to design and deploy ... 40 percent on the development time of clinical ... PULSE,s ability to provide pre-validated programs so developers ...
(Date:2/9/2010)... Md. , Feb. 9 ... today that it will release its fourth quarter ... on Tuesday, February 16, 2010 . ,, ... Tuesday, February 16, 2010 , at ... accessible by dialing 1-888-695-0608, with international callers dialing ...
(Date:2/8/2010)... February 8 QIAGEN,(NASDAQ: ... that its wholly,owned subsidiary DxS has acquired the ... Johns Hopkins University to develop real-time-PCR and,endpoint ... the PI3K gene could,be a key biomarker for ... The studies suggest that mutations in the PI3K ...
(Date:2/8/2010)... BEIJING , Feb. 8 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,Inc. (the "Company") (Nasdaq: CMED ... at the,following investor conferences in March 2010 : , , Investor Conference ... Location, Rodman & Renshaw ... China Investment ... Beijing, Conference, Credit ...
Breaking Biology Technology:endpoint Saves Money and Time for Medical Research Teams Through PULSE 2endpoint Saves Money and Time for Medical Research Teams Through PULSE 3QIAGEN Acquires Exclusive Licence for Key PI3K gene 2QIAGEN Acquires Exclusive Licence for Key PI3K gene 3QIAGEN Acquires Exclusive Licence for Key PI3K gene 4China Medical Technologies to Participate Investor Conferences in March 2010 2
... Oncothyreon Inc. (Nasdaq: ONTY ) (TSX: ONY) ... investors to purchase approximately 3.88 million shares of its ... shares of its common stock for gross proceeds of ... the shares and warrants for $2.85 per unit (each ...
... (OTC Bulletin Board: MCLN) announced today that it has ... Company,s existing Common Stock Purchase Warrants with Initial Exercise ... ("Existing Warrants") for newly issued Common Stock Purchase Warrants, ... lesser number shares of our common stock, par value ...
... ROTTERDAM, Netherlands, May 19 InfraReDx, Inc. announced today the ... uses both light and sound to image coronary plaques. Working ... van der Ent performed the procedures on May 11, 2009 ... combination catheter provides the benefits of both IVUS and NIRS ...
Other Biology Technology:Oncothyreon announces commitments to purchase $11.1 million of company securities in a registered direct financing 2MedClean Technologies, Inc. Announces Private Offer to Exchange Warrants 2MedClean Technologies, Inc. Announces Private Offer to Exchange Warrants 3MedClean Technologies, Inc. Announces Private Offer to Exchange Warrants 4First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter 2First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter 3
acridine orange 10-nonyl bromide (nonyl acridine orange)...
Because it is manufactured at our ISO 9001–certified facilities in Eugene, Oregon, we can guarantee that FluoroPure grade propidium iodide is greater than or equal to 98% pure by HPLC....
MOUSE ANTI RAT RT1Bu Immunogen: Rat thymocyte membrane glycoproteins...
... of BAC (100+kb), fosmid (40kb), and large ... than any othe BAC vector. On command ... and easy recombinant DNA purification. Available with ... VC) vectors for the highest insert stability. ...
Biology Products: